In silico Plasma Protein Binding Studies of Selected Group of Drugs Using TLC and HPLC Retention Data.
Karolina WanatGrażyna ŻydekAdam HeknerElżbieta BrzezińskaPublished in: Pharmaceuticals (Basel, Switzerland) (2021)
Plasma protein binding is an important determinant of the pharmacokinetic properties of chemical compounds in living organisms. The aim of the present study was to determine the index of protein binding affinity based on chromatographic experiments. The question is which chromatographic environment will best mimic the drug-protein binding conditions. Retention data from normal phase thin-layer liquid chromatography (NP TLC), reversed phase (RP) TLC and HPLC chromatography experiments with 129 active pharmaceutical ingredients (APIs) were collected. The stationary phase of the TLC plates was modified with protein and the HPLC column was filled with immobilized human serum albumin. In both chromatographic methods, the mobile phase was based on a buffer with a pH of 7.4 to mimic physiological conditions. Chemometric analyses were performed to compare multiple linear regression models (MLRs) with retention data, using protein binding values as the dependent variable. In the course of the analysis, APIs were divided into acidic, basic and neutral groups, and separate models were created for each group. The MLR models had a coefficient of determination between 0.73 and 0.91, with the highest values from NP TLC data.
Keyphrases
- simultaneous determination
- liquid chromatography
- binding protein
- mass spectrometry
- ms ms
- electronic health record
- protein protein
- solid phase extraction
- amino acid
- big data
- magnetic resonance imaging
- magnetic resonance
- emergency department
- dna binding
- computed tomography
- high resolution mass spectrometry
- machine learning
- human serum albumin
- multidrug resistant
- molecular docking
- deep learning